Literature DB >> 7591566

Assessment of adrenal surgery on creatinine clearance in patients with phaeochromocytoma.

T Nakada1, H Kaneko, Y Kubota, M Watanabe, I Sasagawa, T Yagisawa, H Yamanaka, K Imai.   

Abstract

Sequential changes in creatinine clearance (Ccr) were determined in 14 patients undergoing operation for phaeochromocytoma. All patients had been given alpha-adrenergic antagonists 2 weeks before surgery. In the younger group (mean age 40 +/- 2 years), Ccr improved following adrenal surgery. Urinary concentrations of epinephrine, norepinephrine and total catecholamines correlated inversely with Ccr. A similar inverse relationship was noted between tissue norepinephrine concentration expressed as microgram/g and Ccr to a lesser extent. In older patients (mean age 69 +/- 2 years) Ccr remained unchanged by this surgical procedure. No significant correlations were found between both parameters in the older group. It appears reasonable to presume that excessive amount of catecholamine plays an important role in the impairment of Ccr in relatively young patients with phaeochromocytoma, but other possibilities as regards the sequence of this phenomenon must be pursued in older patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591566     DOI: 10.1007/BF02551307

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  22 in total

1.  A note on pheochromocytoma and renal hypertension.

Authors:  J H HARRISON; F H GARDNER; G J DAMMIN
Journal:  J Urol       Date:  1958-02       Impact factor: 7.450

2.  Catecholamine metabolism in pheochromocytoma and normal adrenal medullae.

Authors:  T Nakada; H Furuta; T Katayama
Journal:  J Urol       Date:  1988-12       Impact factor: 7.450

3.  Plasma catecholamine changes during excision of pheochromocytoma.

Authors:  K A Newell; R A Prinz; M H Brooks; S N Glisson; A L Barbato; R J Freeark
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

4.  [Catecholamine content in the human adrenal gland].

Authors:  T Nakada; H Koike; T Katayama
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1985-02

5.  Pheochromocytoma and renovascular hypertension. A case report on a review of the literature.

Authors:  A Alvestrand; J Bergström; B Wehle
Journal:  Acta Med Scand       Date:  1977

6.  Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma.

Authors:  L J Helman; P S Cohen; S D Averbuch; M J Cooper; H R Keiser; M A Israel
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

7.  The nature of the glomerular injury in minimal change and focal sclerosing glomerulopathies.

Authors:  J A Winetz; C R Robertson; H V Golbetz; B J Carrie; W R Salyer; B D Myers
Journal:  Am J Kidney Dis       Date:  1981-09       Impact factor: 8.860

8.  Enhanced protein synthesis in the renal arteries of genetically hypertensive rats: its possible role in causing hypertension.

Authors:  T Nakada
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

9.  Bilateral adrenal phaeochromocytomas associated with unilateral renal artery stenosis.

Authors:  A P Burns; P R O'Connell; D J Murnaghan; M P Brady
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

10.  Effect of atrial natriuretic peptide on catecholamine release from human pheochromocytoma.

Authors:  M Nakamaru; T Ogihara; H Saito; H Rakugi; K Hashizume; A Yamatodani; H Wada; Y Kumahara
Journal:  Acta Endocrinol (Copenh)       Date:  1989-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.